LncRNA/CircRNA-miRNA-mRNA Axis in Atherosclerotic Inflammation: Research Progress

World health statistics 2021: Monitoring health for the SDGs, sustainable development goals. 2021. Available from: who.int/publications/i/item/9789240027053

Ben, J.; Jiang, B.; Wang, D.; Liu, Q.; Zhang, Y.; Qi, Y.; Tong, X.; Chen, L.; Liu, X.; Zhang, Y.; Zhu, X.; Li, X.; Zhang, H.; Bai, H.; Yang, Q.; Ma, J.; Wiemer, E.A.C.; Xu, Y.; Chen, Q. Major vault protein suppresses obesity and atherosclerosis through inhibiting IKK–NF-κB signaling mediated inflammation. Nat. Commun., 2019, 10(1), 1801.
[http://dx.doi.org/10.1038/s41467-019-09588-x] [PMID: 30996248]

Gillrie, M.R.; Krishnegowda, G.; Lee, K.; Buret, A.G.; Robbins, S.M.; Looareesuwan, S.; Gowda, D.C.; Ho, M. Src-family kinase–dependent disruption of endothelial barrier function by Plasmodium falciparum merozoite proteins. Blood, 2007, 110(9), 3426-3435.
[http://dx.doi.org/10.1182/blood-2007-04-084582] [PMID: 17693580]

Joshi, A.A.; Lerman, J.B.; Dey, A.K.; Sajja, A.P.; Belur, A.D.; Elnabawi, Y.A.; Rodante, J.A.; Aberra, T.M.; Chung, J.; Salahuddin, T.; Natarajan, B.; Dave, J.; Goyal, A.; Groenendyk, J.W.; Rivers, J.P.; Baumer, Y.; Teague, H.L.; Playford, M.P.; Bluemke, D.A.; Ahlman, M.A.; Chen, M.Y.; Gelfand, J.M.; Mehta, N.N. Association between aortic vascular inflammation and coronary artery plaque characteristics in psoriasis. JAMA Cardiol., 2018, 3(10), 949-956.
[http://dx.doi.org/10.1001/jamacardio.2018.2769] [PMID: 30208407]

Wang, Z.T.; Wang, Z.; Hu, Y.W. Possible roles of platelet-derived microparticles in atherosclerosis. Atherosclerosis, 2016, 248, 10-16.
[http://dx.doi.org/10.1016/j.atherosclerosis.2016.03.004] [PMID: 26978582]

Stauss, R.D.; Grosse, G.M.; Neubert, L.; Falk, C.S.; Jonigk, D.; Kühnel, M.P.; Gabriel, M.M.; Schuppner, R.; Lichtinghagen, R.; Wilhelmi, M.; Weissenborn, K.; Schrimpf, C. Distinct systemic cytokine networks in symptomatic and asymptomatic carotid stenosis. Sci. Rep., 2020, 10(1), 21963.
[http://dx.doi.org/10.1038/s41598-020-78941-8] [PMID: 33319833]

Li, X.; Guo, D.; Chen, Y.; Hu, Y.; Zhang, F. Effects of altered levels of pro- and anti-inflammatory mediators on locations of in-stent reocclusions in elderly patients. Mediators Inflamm., 2020, 2020, 1-12.
[http://dx.doi.org/10.1155/2020/1719279] [PMID: 33029103]

Bäck, M.; Yurdagul, A., Jr; Tabas, I.; Öörni, K.; Kovanen, P.T. Inflammation and its resolution in atherosclerosis: Mediators and therapeutic opportunities. Nat. Rev. Cardiol., 2019, 16(7), 389-406.
[http://dx.doi.org/10.1038/s41569-019-0169-2] [PMID: 30846875]

Ridker, P.M.; Everett, B.M.; Thuren, T.; MacFadyen, J.G.; Chang, W.H.; Ballantyne, C.; Fonseca, F.; Nicolau, J.; Koenig, W.; Anker, S.D.; Kastelein, J.J.P.; Cornel, J.H.; Pais, P.; Pella, D.; Genest, J.; Cifkova, R.; Lorenzatti, A.; Forster, T.; Kobalava, Z.; Vida-Simiti, L.; Flather, M.; Shimokawa, H.; Ogawa, H.; Dellborg, M.; Rossi, P.R.F.; Troquay, R.P.T.; Libby, P.; Glynn, R.J. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med., 2017, 377(12), 1119-1131.
[http://dx.doi.org/10.1056/NEJMoa1707914] [PMID: 28845751]

Vahdat-Lasemi, F.; Aghaee-Bakhtiari, S.H.; Tasbandi, A.; Jaafari, M.R.; Sahebkar, A. Targeting interleukin‐β by plant‐derived natural products: Implications for the treatment of atherosclerotic cardiovascular disease. Phytother. Res., 2021, 35(10), 5596-5622.
[http://dx.doi.org/10.1002/ptr.7194] [PMID: 34390063]

Carninci, P.; Kasukawa, T.; Katayama, S.; Gough, J.; Frith, M.C.; Maeda, N.; Oyama, R.; Ravasi, T.; Lenhard, B.; Wells, C.; Kodzius, R.; Shimokawa, K.; Bajic, V.B.; Brenner, S.E.; Batalov, S.; Forrest, A.R.R.; Zavolan, M.; Davis, M.J.; Wilming, L.G.; Aidinis, V.; Allen, J.E.; Ambesi-Impiombato, A.; Apweiler, R.; Aturaliya, R.N.; Bailey, T.L.; Bansal, M.; Baxter, L.; Beisel, K.W.; Bersano, T.; Bono, H.; Chalk, A.M.; Chiu, K.P.; Choudhary, V.; Christoffels, A.; Clutterbuck, D.R.; Crowe, M.L.; Dalla, E.; Dalrymple, B.P.; de Bono, B.; Gatta, G.D.; di Bernardo, D.; Down, T.; Engstrom, P.; Fagiolini, M.; Faulkner, G.; Fletcher, C.F.; Fukushima, T.; Furuno, M.; Futaki, S.; Gariboldi, M.; Georgii-Hemming, P.; Gingeras, T.R.; Gojobori, T.; Green, R.E.; Gustincich, S.; Harbers, M.; Hayashi, Y.; Hensch, T.K.; Hirokawa, N.; Hill, D.; Huminiecki, L.; Iacono, M.; Ikeo, K.; Iwama, A.; Ishikawa, T.; Jakt, M.; Kanapin, A.; Katoh, M.; Kawasawa, Y.; Kelso, J.; Kitamura, H.; Kitano, H.; Kollias, G.; Krishnan, S.P.T.; Kruger, A.; Kummerfeld, S.K.; Kurochkin, I.V.; Lareau, L.F.; Lazarevic, D.; Lipovich, L.; Liu, J.; Liuni, S.; McWilliam, S.; Babu, M.M.; Madera, M.; Marchionni, L.; Matsuda, H.; Matsuzawa, S.; Miki, H.; Mignone, F.; Miyake, S.; Morris, K.; Mottagui-Tabar, S.; Mulder, N.; Nakano, N.; Nakauchi, H.; Ng, P.; Nilsson, R.; Nishiguchi, S.; Nishikawa, S.; Nori, F.; Ohara, O.; Okazaki, Y.; Orlando, V.; Pang, K.C.; Pavan, W.J.; Pavesi, G.; Pesole, G.; Petrovsky, N.; Piazza, S.; Reed, J.; Reid, J.F.; Ring, B.Z.; Ringwald, M.; Rost, B.; Ruan, Y.; Salzberg, S.L.; Sandelin, A.; Schneider, C.; Schönbach, C.; Sekiguchi, K.; Semple, C.A.M.; Seno, S.; Sessa, L.; Sheng, Y.; Shibata, Y.; Shimada, H.; Shimada, K.; Silva, D.; Sinclair, B.; Sperling, S.; Stupka, E.; Sugiura, K.; Sultana, R.; Takenaka, Y.; Taki, K.; Tammoja, K.; Tan, S.L.; Tang, S.; Taylor, M.S.; Tegner, J.; Teichmann, S.A.; Ueda, H.R.; van Nimwegen, E.; Verardo, R.; Wei, C.L.; Yagi, K.; Yamanishi, H.; Zabarovsky, E.; Zhu, S.; Zimmer, A.; Hide, W.; Bult, C.; Grimmond, S.M.; Teasdale, R.D.; Liu, E.T.; Brusic, V.; Quackenbush, J.; Wahlestedt, C.; Mattick, J.S.; Hume, D.A.; Kai, C.; Sasaki, D.; Tomaru, Y.; Fukuda, S.; Kanamori-Katayama, M.; Suzuki, M.; Aoki, J.; Arakawa, T.; Iida, J.; Imamura, K.; Itoh, M.; Kato, T.; Kawaji, H.; Kawagashira, N.; Kawashima, T.; Kojima, M.; Kondo, S.; Konno, H.; Nakano, K.; Ninomiya, N.; Nishio, T.; Okada, M.; Plessy, C.; Shibata, K.; Shiraki, T.; Suzuki, S.; Tagami, M.; Waki, K.; Watahiki, A.; Okamura-Oho, Y.; Suzuki, H.; Kawai, J.; Hayashizaki, Y. The transcriptional landscape of the mammalian genome. Science, 2005, 309(5740), 1559-1563.
[http://dx.doi.org/10.1126/science.1112014] [PMID: 16141072]

Fabian, M.R.; Sonenberg, N.; Filipowicz, W. Regulation of mRNA Translation and Stability by microRNAs. Annu. Rev. Biochem., 2010, 79(1), 351-379.
[http://dx.doi.org/10.1146/annurev-biochem-060308-103103] [PMID: 20533884]

Janas, M.M.; Wang, B.; Harris, A.S.; Aguiar, M.; Shaffer, J.M.; Subrahmanyam, Y.V.B.K.; Behlke, M.A.; Wucherpfennig, K.W.; Gygi, S.P.; Gagnon, E.; Novina, C.D. Alternative RISC assembly: Binding and repression of microRNA–mRNA duplexes by human Ago proteins. RNA, 2012, 18(11), 2041-2055.
[http://dx.doi.org/10.1261/rna.035675.112] [PMID: 23019594]

Bridges, M.C.; Daulagala, A.C.; Kourtidis, A. LNCcation: lncRNA localization and function. J. Cell Biol., 2021, 220(2), e202009045.
[http://dx.doi.org/10.1083/jcb.202009045] [PMID: 33464299]

Denzler, R.; Agarwal, V.; Stefano, J.; Bartel, D.P.; Stoffel, M. Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance. Mol. Cell, 2014, 54(5), 766-776.
[http://dx.doi.org/10.1016/j.molcel.2014.03.045] [PMID: 24793693]

Statello, L.; Guo, C.J.; Chen, L.L.; Huarte, M. Gene regulation by long non-coding RNAs and its biological functions. Nat. Rev. Mol. Cell Biol., 2021, 22(2), 96-118.
[http://dx.doi.org/10.1038/s41580-020-00315-9] [PMID: 33353982]

Kristensen, L.S.; Andersen, M.S.; Stagsted, L.V.W.; Ebbesen, K.K.; Hansen, T.B.; Kjems, J. The biogenesis, biology and characterization of circular RNAs. Nat. Rev. Genet., 2019, 20(11), 675-691.
[http://dx.doi.org/10.1038/s41576-019-0158-7] [PMID: 31395983]

Chen, L.L. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat. Rev. Mol. Cell Biol., 2020, 21(8), 475-490.
[http://dx.doi.org/10.1038/s41580-020-0243-y] [PMID: 32366901]

Salmena, L.; Poliseno, L.; Tay, Y.; Kats, L.; Pandolfi, P.P. A ceRNA hypothesis: The Rosetta Stone of a hidden RNA language? Cell, 2011, 146(3), 353-358.
[http://dx.doi.org/10.1016/j.cell.2011.07.014] [PMID: 21802130]

Navarro, E.; Mallén, A.; Cruzado, J.M.; Torras, J.; Hueso, M. Unveiling ncRNA regulatory axes in atherosclerosis progression. Clin. Transl. Med., 2020, 9(1), 5.
[http://dx.doi.org/10.1186/s40169-020-0256-3] [PMID: 32009226]

Martens, C.R.; Bansal, S.S.; Accornero, F. Cardiovascular inflammation: RNA takes the lead. J. Mol. Cell. Cardiol., 2019, 129, 247-256.
[http://dx.doi.org/10.1016/j.yjmcc.2019.03.012] [PMID: 30880251]

Gimbrone, M.A., Jr; García-Cardeña, G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ. Res., 2016, 118(4), 620-636.
[http://dx.doi.org/10.1161/CIRCRESAHA.115.306301] [PMID: 26892962]

Jaffe, I.Z.; Jaisser, F. Endothelial cell mineralocorticoid receptors: turning cardiovascular risk factors into cardiovascular dysfunction. Hypertension, 2014, 63(5), 915-917.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.114.01997] [PMID: 24566083]

Sitia, S.; Tomasoni, L.; Atzeni, F.; Ambrosio, G.; Cordiano, C.; Catapano, A.; Tramontana, S.; Perticone, F.; Naccarato, P.; Camici, P.; Picano, E.; Cortigiani, L.; Bevilacqua, M.; Milazzo, L.; Cusi, D.; Barlassina, C.; Sarzi-Puttini, P.; Turiel, M. From endothelial dysfunction to atherosclerosis. Autoimmun. Rev., 2010, 9(12), 830-834.
[http://dx.doi.org/10.1016/j.autrev.2010.07.016] [PMID: 20678595]

Soeters, P.B.; Wolfe, R.R.; Shenkin, A. Hypoalbuminemia: Pathogenesis and clinical significance. JPEN J. Parenter. Enteral Nutr., 2019, 43(2), 181-193.
[http://dx.doi.org/10.1002/jpen.1451] [PMID: 30288759]

Khwaja, B.; Thankam, F.G.; Agrawal, D.K. Mitochondrial DAMPs and altered mitochondrial dynamics in OxLDL burden in atherosclerosis. Mol. Cell. Biochem., 2021, 476(4), 1915-1928.
[http://dx.doi.org/10.1007/s11010-021-04061-0] [PMID: 33492610]

Giddens, D.P.; Zarins, C.K.; Glagov, S. The role of fluid mechanics in the localization and detection of atherosclerosis. J. Biomech. Eng., 1993, 115(4B), 588-594.
[http://dx.doi.org/10.1115/1.2895545] [PMID: 8302046]

Zhou, J.; Li, Y.S.; Chien, S. Shear stress-initiated signaling and its regulation of endothelial function. Arterioscler. Thromb. Vasc. Biol., 2014, 34(10), 2191-2198.
[http://dx.doi.org/10.1161/ATVBAHA.114.303422] [PMID: 24876354]

Sweet, D.R.; Fan, L.; Hsieh, P.N.; Jain, M.K. Krüppel-like factors in vascular inflammation: Mechanistic insights and therapeutic potential. Front. Cardiovasc. Med., 2018, 5, 6.
[http://dx.doi.org/10.3389/fcvm.2018.00006] [PMID: 29459900]

Niu, N.; Xu, S.; Xu, Y.; Little, P.J.; Jin, Z.G. Targeting mechanosensitive transcription factors in atherosclerosis. Trends Pharmacol. Sci., 2019, 40(4), 253-266.
[http://dx.doi.org/10.1016/j.tips.2019.02.004] [PMID: 30826122]

Mun, G.I.; Boo, Y.C. A regulatory role of Kruppel-like factor 4 in endothelial argininosuccinate synthetase 1 expression in response to laminar shear stress. Biochem. Biophys. Res. Commun., 2012, 420(2), 450-455.
[http://dx.doi.org/10.1016/j.bbrc.2012.03.016] [PMID: 22430140]

Shan, K.; Jiang, Q.; Wang, X.Q.; Wang, Y.N.Z.; Yang, H.; Yao, M.D.; Liu, C.; Li, X.M.; Yao, J.; Liu, B.; Zhang, Y.Y. J, Y.; Yan, B. Role of long non-coding RNA-RNCR3 in atherosclerosis-related vascular dysfunction. Cell Death Dis., 2016, 7(6), e2248.
[http://dx.doi.org/10.1038/cddis.2016.145] [PMID: 27253412]

Lu, Q.; Meng, Q.; Qi, M.; Li, F.; Liu, B. Shear-sensitive lncRNA AF131217.1 inhibits inflammation in HUVECs via regulation of KLF4. Hypertension, 2019, 73(5), e25-e34.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.12476] [PMID: 30905197]

Mukovozov, I.; Huang, Y.W.; Zhang, Q.; Liu, G.Y.; Siu, A.; Sokolskyy, Y.; Patel, S.; Hyduk, S.J.; Kutryk, M.J.B.; Cybulsky, M.I.; Robinson, L.A. The neurorepellent slit2 inhibits postadhesion stabilization of monocytes tethered to vascular endothelial cells. J. Immunol., 2015, 195(7), 3334-3344.
[http://dx.doi.org/10.4049/jimmunol.1500640] [PMID: 26297762]

Zhao, H.; Anand, A.R.; Ganju, R.K. Slit2-Robo4 pathway modulates lipopolysaccharide-induced endothelial inflammation and its expression is dysregulated during endotoxemia. J. Immunol., 2014, 192(1), 385-393.
[http://dx.doi.org/10.4049/jimmunol.1302021] [PMID: 24272999]

Li, S.; Huang, T.; Qin, L.; Yin, L. Circ_0068087 silencing ameliorates oxidized low-density lipoprotein-induced dysfunction in vascular endothelial cells depending on mir-186-5p-mediated regulation of roundabout guidance receptor 1. Front. Cardiovasc. Med., 2021, 8, 650374.
[http://dx.doi.org/10.3389/fcvm.2021.650374] [PMID: 34124191]

Zhang, Y.; Li, W.; Li, H.; Zhou, M.; Zhang, J.; Fu, Y.; Zhang, C.; Sun, X. Circ_USP36 silencing attenuates oxidized low-density lipoprotein-induced dysfunction in endothelial cells in atherosclerosis through mediating miR-197-3p/ROBO1 axis. J. Cardiovasc. Pharmacol., 2021, 78(5), e761-e772.
[http://dx.doi.org/10.1097/FJC.0000000000001124] [PMID: 34369900]

Rochette, L.; Lorin, J.; Zeller, M.; Guilland, J.C.; Lorgis, L.; Cottin, Y.; Vergely, C. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: Possible therapeutic targets? Pharmacol. Ther., 2013, 140(3), 239-257.
[http://dx.doi.org/10.1016/j.pharmthera.2013.07.004] [PMID: 23859953]

Munro, J.M.; Cotran, R.S. The pathogenesis of atherosclerosis: Atherogenesis and inflammation. Lab. Invest., 1988, 58(3), 249-261.
[PMID: 3279259]

Jaipersad, A.S.; Lip, G.Y.H.; Silverman, S.; Shantsila, E. The role of monocytes in angiogenesis and atherosclerosis. J. Am. Coll. Cardiol., 2014, 63(1), 1-11.
[http://dx.doi.org/10.1016/j.jacc.2013.09.019] [PMID: 24140662]

Peng, K.; Jiang, P.; Du, Y.; Zeng, D.; Zhao, J.; Li, M.; Xia, C.; Xie, Z.; Wu, J. Oxidized low‐density lipoprotein accelerates the injury of endothelial cells via CIRC‐USP36/MIR ‐98‐5p/VCAM1 axis. IUBMB Life, 2021, 73(1), 177-187.
[http://dx.doi.org/10.1002/iub.2419] [PMID: 33249762]

Zhang, D.; Zhang, G.; Yu, K.; Zhang, X.; Jiang, A. Circ_0003204 knockdown protects endothelial cells against oxidized low-density lipoprotein-induced injuries by targeting the miR-491-5p-ICAM1 pathway. J. Thromb. Thrombolysis, 2022, 53(2), 302-312.
[http://dx.doi.org/10.1007/s11239-021-02606-0] [PMID: 34797473]

Lamb, D.J.; Modjtahedi, H.; Plant, N.J.; Ferns, G.A.A. EGF mediates monocyte chemotaxis and macrophage proliferation and EGF receptor is expressed in atherosclerotic plaques. Atherosclerosis, 2004, 176(1), 21-26.
[http://dx.doi.org/10.1016/j.atherosclerosis.2004.04.012] [PMID: 15306170]

Xiong, F.; Mao, R.; Zhang, L.; Zhao, R.; Tan, K.; Liu, C.; Xu, J.; Du, G.; Zhang, T. CircNPHP4 in monocyte-derived small extracellular vesicles controls heterogeneous adhesion in coronary heart atherosclerotic disease. Cell Death Dis., 2021, 12(10), 948.
[http://dx.doi.org/10.1038/s41419-021-04253-y] [PMID: 34650036]

Dunaway, L.S.; Pollock, J.S. HDAC1: an environmental sensor regulating endothelial function. Cardiovasc. Res., 2022, 118(8), 1885-1903.
[http://dx.doi.org/10.1093/cvr/cvab198] [PMID: 34264338]

Zhang, X.; Lu, J.; Zhang, Q.; Luo, Q.; Liu, B. CircRNA RSF1 regulated ox-LDL induced vascular endothelial cells proliferation, apoptosis and inflammation through modulating miR-135b-5p/HDAC1 axis in atherosclerosis. Biol. Res., 2021, 54(1), 11.
[http://dx.doi.org/10.1186/s40659-021-00335-5] [PMID: 33757583]

Seccia, T.M.; Rigato, M.; Ravarotto, V.; Calò, L.A. ROCK (RhoA/Rho Kinase) in cardiovascular–renal pathophysiology: A review of new advancements. J. Clin. Med., 2020, 9(5), 1328.
[http://dx.doi.org/10.3390/jcm9051328] [PMID: 32370294]

Noma, K.; Oyama, N.; Liao, J.K. Physiological role of ROCKs in the cardiovascular system. Am. J. Physiol. Cell Physiol., 2006, 290(3), C661-C668.
[http://dx.doi.org/10.1152/ajpcell.00459.2005] [PMID: 16469861]

Shan, H.; Guo, D.; Zhang, S.; Qi, H.; Liu, S.; Du, Y.; He, Y.; Wang, B.; Xu, M.; Yu, X. RETRACTED ARTICLE: SNHG6 modulates oxidized low-density lipoprotein-induced endothelial cells injury through miR-135a-5p/ROCK in atherosclerosis. Cell Biosci., 2020, 10(1), 4.
[http://dx.doi.org/10.1186/s13578-019-0371-2] [PMID: 31921409]

Shimada, H.; Rajagopalan, L.E. Rho kinase-2 activation in human endothelial cells drives lysophosphatidic acid-mediated expression of cell adhesion molecules via NF-kappaB p65. J. Biol. Chem., 2010, 285(17), 12536-12542.
[http://dx.doi.org/10.1074/jbc.M109.099630] [PMID: 20164172]

Miao, J.; Wang, B.; Shao, R.; Wang, Y. CircUSP36 knockdown alleviates oxidized low density lipoprotein induced cell injury and inflammatory responses in human umbilical vein endothelial cells via the miR 20a 5p/ROCK2 axis. Int. J. Mol. Med., 2021, 47(4), 40.
[http://dx.doi.org/10.3892/ijmm.2021.4873] [PMID: 33576448]

Li, X.; Kang, X.; Di, Y.; Sun, S.; Yang, L.; Wang, B.; Ji, Z. CircCHMP5 contributes to Ox-LDL-induced endothelial cell injury through the regulation of MiR-532-5p/ROCK2 axis. Cardiovasc. Drugs Ther., 2022.
[http://dx.doi.org/10.1007/s10557-022-07316-0]

Li, L.; Du, Z.; Rong, B.; Zhao, D.; Wang, A.; Xu, Y.; Zhang, H.; Bai, X.; Zhong, J. Foam cells promote atherosclerosis progression by releasing CXCL12. Biosci. Rep., 2020, 40(1), BSR20193267.
[http://dx.doi.org/10.1042/BSR20193267] [PMID: 31894855]

Su, G.; Sun, G.; Lv, J.; Zhang, W.; Liu, H.; Tang, Y.; Su, H. Hsa_circ_0004831 downregulation is partially responsible for atorvastatinalleviated human umbilical vein endothelial cell injuries induced by ox-LDL through targeting the miR-182-5p/CXCL12 axis. BMC Cardiovasc. Disord., 2021, 21(1), 221.
[http://dx.doi.org/10.1186/s12872-021-01998-4] [PMID: 33932991]

Chen, G.; Ward, M.F.; Sama, A.E.; Wang, H. Extracellular HMGB1 as a proinflammatory cytokine. J. Interferon Cytokine Res., 2004, 24(6), 329-333.
[http://dx.doi.org/10.1089/107999004323142187] [PMID: 15212706]

Calderon-Pelaez, M.A.; Coronel-Ruiz, C.; Castellanos, J.E.; Velandia-Romero, M.L. Endothelial dysfunction, HMGB1, and dengue: An enigma to solve Viruses-Basel., 2022, 14(8)

van Beijnum, J.R.; Buurman, W.A.; Griffioen, A.W. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis, 2008, 11(1), 91-99.
[http://dx.doi.org/10.1007/s10456-008-9093-5] [PMID: 18264787]

Yang, J.; Huang, C.; Yang, J.; Jiang, H.; Ding, J. Statins attenuate high mobility group box-1 protein induced vascular endothelial activation: A key role for TLR4/NF-κB signaling pathway. Mol. Cell. Biochem., 2010, 345(1-2), 189-195.
[http://dx.doi.org/10.1007/s11010-010-0572-9] [PMID: 20714791]

Zheng, Z.; Zhang, G.; Liang, X.; Li, T. LncRNA OIP5-AS1 facilitates ox-LDL-induced endothelial cell injury through the miR-98-5p/HMGB1 axis. Mol. Cell. Biochem., 2021, 476(1), 443-455.
[http://dx.doi.org/10.1007/s11010-020-03921-5] [PMID: 32990894]

Umahara, T.; Uchihara, T.; Hirao, K.; Shimizu, S.; Hashimoto, T.; Kohno, M.; Hanyu, H. Essential autophagic protein Beclin 1 localizes to atherosclerotic lesions of human carotid and major intracranial arteries. J. Neurol. Sci., 2020, 414, 116836.
[http://dx.doi.org/10.1016/j.jns.2020.116836] [PMID: 32344218]

Dong, G.; Yang, S.; Cao, X.; Yu, N.; Yu, J.; Qu, X. Low shear stress-induced autophagy alleviates cell apoptosis in HUVECs. Mol. Med. Rep., 2017, 15(5), 3076-3082.
[http://dx.doi.org/10.3892/mmr.2017.6401] [PMID: 28350133]

Meng, Q.; Pu, L.; Qi, M.; Li, S.; Sun, B.; Wang, Y.; Liu, B.; Li, F. Laminar shear stress inhibits inflammation by activating autophagy in human aortic endothelial cells through HMGB1 nuclear translocation. Commun. Biol., 2022, 5(1), 425.
[http://dx.doi.org/10.1038/s42003-022-03392-y] [PMID: 35523945]

Landry, N.M.; Cohen, S.; Dixon, I.M.C. Periostin in cardiovascular disease and development: A tale of two distinct roles. Basic Res. Cardiol., 2018, 113(1), 1.
[http://dx.doi.org/10.1007/s00395-017-0659-5] [PMID: 29101484]

Schwanekamp, J.A.; Lorts, A.; Vagnozzi, R.J.; Vanhoutte, D.; Molkentin, J.D. Deletion of periostin protects against atherosclerosis in mice by altering inflammation and extracellular matrix remodeling. Arterioscler. Thromb. Vasc. Biol., 2016, 36(1), 60-68.
[http://dx.doi.org/10.1161/ATVBAHA.115.306397] [PMID: 26564821]

Hakuno, D.; Kimura, N.; Yoshioka, M.; Mukai, M.; Kimura, T.; Okada, Y.; Yozu, R.; Shukunami, C.; Hiraki, Y.; Kudo, A.; Ogawa, S.; Fukuda, K. Periostin advances atherosclerotic and rheumatic cardiac valve degeneration by inducing angiogenesis and MMP production in humans and rodents. J. Clin. Invest., 2010, 120(7), 2292-2306.
[http://dx.doi.org/10.1172/JCI40973] [PMID: 20551517]

Cao, L.; Zhang, Z.; Li, Y.; Zhao, P.; Chen, Y. LncRNA H19/miR-let-7 axis participates in the regulation of ox-LDL-induced endothelial cell injury via targeting periostin. Int. Immunopharmacol., 2019, 72, 496-503.
[http://dx.doi.org/10.1016/j.intimp.2019.04.042] [PMID: 31054453]

Brennan, E.; Wang, B.; McClelland, A.; Mohan, M.; Marai, M.; Beuscart, O.; Derouiche, S.; Gray, S.; Pickering, R.; Tikellis, C.; de Gaetano, M.; Barry, M.; Belton, O.; Ali-Shah, S.T.; Guiry, P.; Jandeleit-Dahm, K.A.M.; Cooper, M.E.; Godson, C.; Kantharidis, P. Protective effect of let-7 miRNA family in regulating inflammation in diabetes-associated atherosclerosis. Diabetes, 2017, 66(8), 2266-2277.
[http://dx.doi.org/10.2337/db16-1405] [PMID: 28487436]

Zhang, W.; Sui, Y. CircBPTF knockdown ameliorates high glucose-induced inflammatory injuries and oxidative stress by targeting the miR-384/LIN28B axis in human umbilical vein endothelial cells. Mol. Cell. Biochem., 2020, 471(1-2), 101-111.
[http://dx.doi.org/10.1007/s11010-020-03770-2] [PMID: 32524321]

Gast, M.; Rauch, B.H.; Haghikia, A.; Nakagawa, S.; Haas, J.; Stroux, A.; Schmidt, D.; Schumann, P.; Weiss, S.; Jensen, L.; Kratzer, A.; Kraenkel, N.; Müller, C.; Börnigen, D.; Hirose, T.; Blankenberg, S.; Escher, F.; Kühl, A.A.; Kuss, A.W.; Meder, B.; Landmesser, U.; Zeller, T.; Poller, W. Long noncoding RNA NEAT1 modulates immune cell functions and is suppressed in early onset myocardial infarction patients. Cardiovasc. Res., 2019, 115(13), 1886-1906.
[http://dx.doi.org/10.1093/cvr/cvz085] [PMID: 30924864]

Guo, J.T.; Wang, L.; Yu, H.B. Knockdown of NEAT1 mitigates ox-LDL-induced injury in human umbilical vein endothelial cells via miR-30c-5p/TCF7 axis. Eur Rev Med Pharmaco, 2020, 24(18), 9633-9644.
[PMID: 33015807]

Sun, X.; Feinberg, M.W. NF-κB and Hypoxia. Am. J. Pathol., 2012, 181(5), 1513-1517.
[http://dx.doi.org/10.1016/j.ajpath.2012.09.001] [PMID: 22999810]

Mitchell, J.P.; Carmody, R.J. NF-κB and the transcriptional control of inflammation. Int. Rev. Cell Mol. Biol., 2018, 335, 41-84.
[http://dx.doi.org/10.1016/bs.ircmb.2017.07.007] [PMID: 29305014]

Razeghian-Jahromi, I.; Karimi, A.A.; Zibaeenezhad, M.J. The role of ANRIL in atherosclerosis. Dis. Markers, 2022, 2022, 1-10.
[http://dx.doi.org/10.1155/2022/8859677] [PMID: 35186169]

Guo, F.; Tang, C.; Li, Y.; Liu, Y.; Lv, P.; Wang, W.; Mu, Y. The interplay of Lnc RNA ANRIL and miR‐181b on the inflammation‐relevant coronary artery disease through mediating NF ‐κB signalling pathway. J. Cell. Mol. Med., 2018, 22(10), 5062-5075.
[http://dx.doi.org/10.1111/jcmm.13790] [PMID: 30079603]

Chen, T.; Li, L.; Ye, B.; Chen, W.; Zheng, G.; Xie, H.; Guo, Y. Knockdown of hsa_circ_0005699 attenuates inflammation and apoptosis induced by ox-LDL in human umbilical vein endothelial cells through regulation of the miR-450b-5p/NFKB1 axis. Mol. Med. Rep., 2022, 26(3), 290.
[http://dx.doi.org/10.3892/mmr.2022.12806] [PMID: 35904173]

Baldwin, A.S., Jr The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu. Rev. Immunol., 1996, 14(1), 649-681.
[http://dx.doi.org/10.1146/annurev.immunol.14.1.649] [PMID: 8717528]

Lin, Z.; Ge, J.; Wang, Z.; Ren, J.; Wang, X.; Xiong, H.; Gao, J.; Zhang, Y.; Zhang, Q. Let-7e modulates the inflammatory response in vascular endothelial cells through ceRNA crosstalk. Sci. Rep., 2017, 7(1), 42498.
[http://dx.doi.org/10.1038/srep42498] [PMID: 28195197]

Li, H.; Sun, B. Toll-like receptor 4 in atherosclerosis. J. Cell. Mol. Med., 2007, 11(1), 88-95.
[http://dx.doi.org/10.1111/j.1582-4934.2007.00011.x] [PMID: 17367503]

Tang, Y.L.; Jiang, J.H.; Wang, S.; Liu, Z.; Tang, X.Q.; Peng, J.; Yang, Y.Z.; Gu, H.F. TLR4/NF-kappaB signaling contributes to chronic unpredictable mild stress-induced atherosclerosis in ApoE-/- mice. PLoS One, 2015, 10(4), e0123685.
[http://dx.doi.org/10.1371/journal.pone.0123685]

Huang, H.; Huang, X.; Yu, H.; Xue, Y.; Zhu, P. Circular RNA circ-RELL1 regulates inflammatory response by miR-6873-3p/MyD88/NF-κB axis in endothelial cells. Biochem. Biophys. Res. Commun., 2020, 525(2), 512-519.
[http://dx.doi.org/10.1016/j.bbrc.2020.02.109] [PMID: 32113679]

Bai, Y.; Liu, X.; Chen, Q.; Chen, T.; Jiang, N.; Guo, Z. Myricetin ameliorates ox-LDL-induced HUVECs apoptosis and inflammation via lncRNA GAS5 up-regulating the expression of miR-29a-3p. Sci. Rep., 2021, 11(1), 19637.
[http://dx.doi.org/10.1038/s41598-021-98916-7] [PMID: 34608195]

Stark, A.K.; Sriskantharajah, S.; Hessel, E.M.; Okkenhaug, K. PI3K inhibitors in inflammation, autoimmunity and cancer. Curr. Opin. Pharmacol., 2015, 23, 82-91.
[http://dx.doi.org/10.1016/j.coph.2015.05.017] [PMID: 26093105]

Ren, M.; Wang, T.; Han, Z.; Fu, P.; Liu, Z.; Ouyang, C. Long noncoding RNA OIP5-AS1 contributes to the progression of atherosclerosis by targeting miR-26a-5p through the AKT/NF-κB pathway. J. Cardiovasc. Pharmacol., 2020, 76(5), 635-644.
[http://dx.doi.org/10.1097/FJC.0000000000000889] [PMID: 32833899]

Zhang, Y.; Xie, B.; Sun, L.; Chen, W.; Jiang, S.L.; Liu, W.; Bian, F.; Tian, H.; Li, R.K. Phenotypic switching of vascular smooth muscle cells in the ‘normal region’ of aorta from atherosclerosis patients is regulated by miR‐145. J. Cell. Mol. Med., 2016, 20(6), 1049-1061.
[http://dx.doi.org/10.1111/jcmm.12825] [PMID: 26992033]

Chanchevalap, S.; Nandan, M.O.; McConnell, B.B.; Charrier, L.; Merlin, D.; Katz, J.P.; Yang, V.W. Kruppel-like factor 5 is an important mediator for lipopolysaccharide-induced proinflammatory response in intestinal epithelial cells. Nucleic Acids Res., 2006, 34(4), 1216-1223.
[http://dx.doi.org/10.1093/nar/gkl014] [PMID: 16500892]

Wang, F.; Ge, J.; Huang, S.; Zhou, C.; Sun, Z.; Song, Y.; Xu, Y.; Ji, Y. KLF5/LINC00346/miR 148a 3p axis regulates inflammation and endothelial cell injury in atherosclerosis. Int. J. Mol. Med., 2021, 48(2), 152.
[http://dx.doi.org/10.3892/ijmm.2021.4985] [PMID: 34165154]

Fu, D.N.; Wang, Y.; Yu, L.J.; Liu, M.J.; Zhen, D. Silenced long non-coding RNA activated by DNA damage elevates microRNA-495-3p to suppress atherosclerotic plaque formation via reducing Krüppel-like factor 5. Exp. Cell Res., 2021, 401(2), 112519.
[http://dx.doi.org/10.1016/j.yexcr.2021.112519] [PMID: 33636159]

Jiang, X.; Chen, L.; Wu, H.; Chen, Y.; Lu, W.; Lu, K. Knockdown of circular ubiquitin-specific peptidase 9 X-linked alleviates oxidized low-density lipoprotein-induced injuries of human umbilical vein endothelial cells by mediating the miR-148b-3p/KLF5 signaling pathway. J. Cardiovasc. Pharmacol., 2021, 78(6), 809-818.
[http://dx.doi.org/10.1097/FJC.0000000000001127] [PMID: 34882112]

Dickson, K.M.; Bhakar, A.L.; Barker, P.A. TRAF6-dependent NF-kB transcriptional activity during mouse development. Dev. Dyn., 2004, 231(1), 122-127.
[http://dx.doi.org/10.1002/dvdy.20110] [PMID: 15305292]

Zhao, J.; Cui, L.; Sun, J.; Xie, Z.; Zhang, L.; Ding, Z.; Quan, X. Notoginsenoside R1 alleviates oxidized low-density lipoprotein-induced apoptosis, inflammatory response, and oxidative stress in HUVECS through modulation of XIST/miR-221-3p/TRAF6 axis. Cell. Signal., 2020, 76, 109781.
[http://dx.doi.org/10.1016/j.cellsig.2020.109781] [PMID: 32947021]

Niture, S.; Moore, J.; Kumar, D. TNFAIP8: Inflammation, immunity and human diseases. J. Cell. Immunol., 2019, 1(2), 29-34.
[PMID: 31723944]

Ji, P.; Song, X.; Lv, Z. Knockdown of circ_0004104 alleviates oxidized low-density lipoprotein-induced vascular endothelial cell injury by regulating miR-100/TNFAIP8 axis. J. Cardiovasc. Pharmacol., 2021, 78(2), 269-279.
[http://dx.doi.org/10.1097/FJC.0000000000001063] [PMID: 34554678]

Huang, X.; Li, Y.; Li, X.; Fan, D.; Xin, H.B.; Fu, M. TRIM14 promotes endothelial activation via activating NF-κB signaling pathway. J. Mol. Cell Biol., 2020, 12(3), 176-189.
[http://dx.doi.org/10.1093/jmcb/mjz040] [PMID: 31070748]

Zhang, C.; Wang, L.; Shen, Y. Circ_0004104 knockdown alleviates oxidized low-density lipoprotein-induced dysfunction in vascular endothelial cells through targeting miR-328-3p/TRIM14 axis in atherosclerosis. BMC Cardiovasc. Disord., 2021, 21(1), 207.
[http://dx.doi.org/10.1186/s12872-021-02012-7] [PMID: 33892646]

Budai, M.M.; Varga, A.; Milesz, S.; Tőzsér, J.; Benkő, S. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages. Mol. Immunol., 2013, 56(4), 471-479.
[http://dx.doi.org/10.1016/j.molimm.2013.05.005] [PMID: 23911403]

Cheng, J.; Liu, Q.; Hu, N.; Zheng, F.; Zhang, X.; Ni, Y.; Liu, J. Downregulation of hsa_circ_0068087 ameliorates TLR4/NF-κB/NLRP3 inflammasome-mediated inflammation and endothelial cell dysfunction in high glucose conditioned by sponging miR-197. Gene, 2019, 709, 1-7.
[http://dx.doi.org/10.1016/j.gene.2019.05.012] [PMID: 31108165]

Verhoef, P.A.; Kertesy, S.B.; Lundberg, K.; Kahlenberg, J.M.; Dubyak, G.R. Inhibitory effects of chloride on the activation of caspase-1, IL-1beta secretion, and cytolysis by the P2X7 receptor. J. Immunol., 2005, 175(11), 7623-7634.
[http://dx.doi.org/10.4049/jimmunol.175.11.7623] [PMID: 16301672]

Tang, T.; Lang, X.; Xu, C.; Wang, X.; Gong, T.; Yang, Y.; Cui, J.; Bai, L.; Wang, J.; Jiang, W.; Zhou, R. CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation. Nat. Commun., 2017, 8(1), 202.
[http://dx.doi.org/10.1038/s41467-017-00227-x] [PMID: 28779175]

Peng, H.; Sun, J.; Li, Y.; Zhang, Y.; Zhong, Y. Circ-USP9X inhibition reduces oxidized low-density lipoprotein–induced endothelial cell injury via the microRNA 599/Chloride intracellular channel 4 axis. J. Cardiovasc. Pharmacol., 2021, 78(4), 560-571.
[http://dx.doi.org/10.1097/FJC.0000000000001104] [PMID: 34269702]

Jing, B.; Hui, Z. Circular RNA_0033596 aggravates endothelial cell injury induced by oxidized low-density lipoprotein via microRNA-217-5p/chloride intracellular channel 4 axis. Bioengineered, 2022, 13(2), 3410-3421.
[http://dx.doi.org/10.1080/21655979.2022.2027062] [PMID: 35081862]

Shao, X.; Liu, Z.; Liu, S.; Lin, N.; Deng, Y. Astragaloside IV alleviates atherosclerosis through targeting circ_0000231/miR-135a-5p/CLIC4 axis in AS cell model in vitro. Mol. Cell. Biochem., 2021, 476(4), 1783-1795.
[http://dx.doi.org/10.1007/s11010-020-04035-8] [PMID: 33439448]

Zhaolin, Z.; Guohua, L.; Shiyuan, W.; Zuo, W. Role of pyroptosis in cardiovascular disease. Cell Prolif., 2019, 52(2), e12563.
[http://dx.doi.org/10.1111/cpr.12563] [PMID: 30525268]

Zhang, Y.; Liu, X.; Bai, X.; Lin, Y.; Li, Z.; Fu, J.; Li, M.; Zhao, T.; Yang, H.; Xu, R.; Li, J.; Ju, J.; Cai, B.; Xu, C.; Yang, B. Melatonin prevents endothelial cell pyroptosis via regulation of long noncoding RNA MEG3/miR-223/NLRP3 axis. J. Pineal Res., 2018, 64(2), e12449.
[http://dx.doi.org/10.1111/jpi.12449] [PMID: 29024030]

Song, Y.; Yang, L.; Guo, R.; Lu, N.; Shi, Y.; Wang, X. Long noncoding RNA MALAT1 promotes high glucose-induced human endothelial cells pyroptosis by affecting NLRP3 expression through competitively binding miR-22. Biochem. Biophys. Res. Commun., 2019, 509(2), 359-366.
[http://dx.doi.org/10.1016/j.bbrc.2018.12.139] [PMID: 30591217]

Ge, Y.; Liu, W.; Yin, W.; Wang, X.; Wang, J.; Zhu, X.; Xu, S. Circular RNA circ_0090231 promotes atherosclerosis in vitro by enhancing NLR family pyrin domain containing 3-mediated pyroptosis of endothelial cells. Bioengineered, 2021, 12(2), 10837-10848.
[http://dx.doi.org/10.1080/21655979.2021.1989260] [PMID: 34637670]

Zhou, R.; Tardivel, A.; Thorens, B.; Choi, I.; Tschopp, J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol., 2010, 11(2), 136-140.
[http://dx.doi.org/10.1038/ni.1831] [PMID: 20023662]

Chen, G.; Li, Y.; Zhang, A.; Gao, L.; Circular, RNA. Circ-BANP regulates oxidized low-density lipoprotein-induced endothelial cell injury through targeting the miR-370/thioredoxin-interacting protein axis. J. Cardiovasc. Pharmacol., 2021, 77(3), 349-359.
[http://dx.doi.org/10.1097/FJC.0000000000000964] [PMID: 33298736]

Lei, X.; Yang, Y. Oxidized low-density lipoprotein contributes to injury of endothelial cells via the circ_0090231/miR-9-5p/TXNIP axis. Cent. Eur. J. Immunol., 2022, 47(1), 41-57.
[http://dx.doi.org/10.5114/ceji.2021.112521] [PMID: 35600155]

Zhang, L.; Yuan, M.; Zhang, L.; Wu, B.; Sun, X. Adiponectin alleviates NLRP3-inflammasome-mediated pyroptosis of aortic endothelial cells by inhibiting FoxO4 in arteriosclerosis. Biochem. Biophys. Res. Commun., 2019, 514(1), 266-272.
[http://dx.doi.org/10.1016/j.bbrc.2019.04.143] [PMID: 31030940]

Mao, X.; Wang, L.; Chen, C.; Tao, L.; Ren, S.; Zhang, L. Circ_0124644 enhances ox-LDL-induced cell damages in human umbilical vein endothelial cells through up-regulating FOXO4 by sponging miR-370-3p. Clin. Hemorheol. Microcirc., 2022, 81(2), 135-147.
[http://dx.doi.org/10.3233/CH-211375] [PMID: 35570481]

Fu, X.; Sun, Z.; Long, Q.; Tan, W.; Ding, H.; Liu, X.; Wu, L.; Wang, Y.; Zhang, W. Glycosides from Buyang Huanwu Decoction inhibit atherosclerotic inflammation via JAK/STAT signaling pathway. Phytomedicine, 2022, 105, 154385.
[http://dx.doi.org/10.1016/j.phymed.2022.154385] [PMID: 35987015]

Ortiz-Muñoz, G.; Martin-Ventura, J.L.; Hernandez-Vargas, P.; Mallavia, B.; Lopez-Parra, V.; Lopez-Franco, O.; Muñoz-Garcia, B.; Fernandez-Vizarra, P.; Ortega, L.; Egido, J.; Gomez-Guerrero, C. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2009, 29(4), 525-531.
[http://dx.doi.org/10.1161/ATVBAHA.108.173781] [PMID: 19164812]

Li, S.; Sun, Y.; Zhong, L.; Xiao, Z.; Yang, M.; Chen, M.; Wang, C.; Xie, X.; Chen, X. The suppression of ox-LDL-induced inflammatory cytokine release and apoptosis of HCAECs by long non-coding RNA-MALAT1 via regulating microRNA-155/SOCS1 pathway. Nutr. Metab. Cardiovasc. Dis., 2018, 28(11), 1175-1187.
[http://dx.doi.org/10.1016/j.numecd.2018.06.017] [PMID: 30314869]

Wang, R.; Zhang, Y.; Xu, L.; Lin, Y.; Yang, X.; Bai, L.; Chen, Y.; Zhao, S.; Fan, J.; Cheng, X.; Liu, E. Protein inhibitor of activated STAT3 suppresses oxidized LDL-induced cell responses during atherosclerosis in apolipoprotein e-deficient mice. Sci. Rep., 2016, 6(1), 36790.
[http://dx.doi.org/10.1038/srep36790] [PMID: 27845432]

Zhou, Q.; Run, Q.; Li, C.Y.; Xiong, X.Y.; Wu, X.L. LncRNA MALAT1 promotes STAT3-mediated endothelial inflammation by counteracting the function of miR-590. Cytogenet. Genome Res., 2020, 160(10), 565-578.
[http://dx.doi.org/10.1159/000509811] [PMID: 33022677]

Cremer, S.; Michalik, K.M.; Fischer, A.; Pfisterer, L.; Jaé, N.; Winter, C.; Boon, R.A.; Muhly-Reinholz, M.; John, D.; Uchida, S.; Weber, C.; Poller, W.; Günther, S.; Braun, T.; Li, D.Y.; Maegdefessel, L.; Perisic Matic, L.; Hedin, U.; Soehnlein, O.; Zeiher, A.; Dimmeler, S. Hematopoietic deficiency of the long noncoding RNA MALAT1 promotes atherosclerosis and plaque inflammation. Circulation, 2019, 139(10), 1320-1334.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.117.029015] [PMID: 30586743]

Chen, P.Y.; Qin, L.; Li, G.; Wang, Z.; Dahlman, J.E.; Malagon-Lopez, J.; Gujja, S.; Cilfone, N.A.; Kauffman, K.J.; Sun, L.; Sun, H.; Zhang, X.; Aryal, B.; Canfran-Duque, A.; Liu, R.; Kusters, P.; Sehgal, A.; Jiao, Y.; Anderson, D.G.; Gulcher, J.; Fernandez-Hernando, C.; Lutgens, E.; Schwartz, M.A.; Pober, J.S.; Chittenden, T.W.; Tellides, G.; Simons, M. Endothelial TGF-β signalling drives vascular inflammation and atherosclerosis. Nat. Metab., 2019, 1(9), 912-926.
[http://dx.doi.org/10.1038/s42255-019-0102-3] [PMID: 31572976]

Singh, N.; Ramji, D. The role of transforming growth factor-β in atherosclerosis. Cytokine Growth Factor Rev., 2006, 17(6), 487-499.
[http://dx.doi.org/10.1016/j.cytogfr.2006.09.002] [PMID: 17056295]

Huang, S.P.; Guan, X.; Kai, G.Y.; Xu, Y.Z.; Xu, Y.; Wang, H.J.; Pang, T.; Zhang, L.Y.; Liu, Y. Broussonin E suppresses LPS-induced inflammatory response in macrophages via inhibiting MAPK pathway and enhancing JAK2-STAT3 pathway. Chin. J. Nat. Med., 2019, 17(5), 372-380.
[http://dx.doi.org/10.1016/S1875-5364(19)30043-3] [PMID: 31171272]

Chen, D.; Wang, K.; Zheng, Y.; Wang, G.; Jiang, M. Exosomes-mediated LncRNA ZEB1-AS1 facilitates cell injuries by miR-590-5p/ETS1 Axis through the TGF-β/Smad pathway in oxidized low-density lipoprotein-induced human umbilical vein endothelial cells. J. Cardiovasc. Pharmacol., 2021, 77(4), 480-490.
[http://dx.doi.org/10.1097/FJC.0000000000000974] [PMID: 33818551]

Bryk, D.; Olejarz, W.; Zapolska-Downar, D. Mitogen-activated protein kinases in atherosclerosis. Postepy Hig. Med. Dosw., 2014, 68, 10-22. [Mitogen-activated protein kinases in atherosclerosis]
[http://dx.doi.org/10.5604/17322693.1085463]

Zhao, J.; Xu, S.; Liu, J. Fibrinopeptide A induces C‐reactive protein expression through the ROS‐ERK1/2/p38‐NF‐κB signal pathway in the human umbilical vascular endothelial cells. J. Cell. Physiol., 2019, 234(8), 13481-13492.
[http://dx.doi.org/10.1002/jcp.28027] [PMID: 30633345]

Wang, L.; Qi, Y.; Wang, Y.; Tang, H.; Li, Z.; Wang, Y.; Tang, S.; Zhu, H. LncRNA MALAT1 suppression protects endothelium against oxLDL-induced inflammation via inhibiting expression of MiR-181b target gene TOX. Oxid. Med. Cell. Longev., 2019, 2019, 1-11.
[http://dx.doi.org/10.1155/2019/8245810] [PMID: 31949884]

Li, K.; Gesang, L.; Dan, Z.; Gusang, L. Genome-wide transcriptional analysis reveals the protection against hypoxia-induced oxidative injury in the intestine of tibetans via the inhibition of GRB2/EGFR/PTPN11 pathways. Oxid. Med. Cell. Longev., 2016, 2016, 1-13.
[http://dx.doi.org/10.1155/2016/6967396] [PMID: 27594973]

Guo, J.; Li, J.; Zhang, J.; Guo, X.; Liu, H.; Li, P.; Zhang, Y.; Lin, C.; Fan, Z. LncRNA PVT1 knockdown alleviated ox-LDL-induced vascular endothelial cell injury and atherosclerosis by miR-153-3p/GRB2 axis via ERK/p38 pathway. Nutr. Metab. Cardiovasc. Dis., 2021, 31(12), 3508-3521.
[http://dx.doi.org/10.1016/j.numecd.2021.08.031] [PMID: 34627697]

Newby, A.C. Metalloproteinase production from macrophages - a perfect storm leading to atherosclerotic plaque rupture and myocardial infarction. Exp. Physiol., 2016, 101(11), 1327-1337.
[http://dx.doi.org/10.1113/EP085567] [PMID: 26969796]

Boutilier, A.J.; Elsawa, S.F. Macrophage polarization states in the tumor microenvironment. Int. J. Mol. Sci., 2021, 22(13), 6995.
[http://dx.doi.org/10.3390/ijms22136995] [PMID: 34209703]

Orecchioni, M.; Ghosheh, Y.; Pramod, A.B.; Ley, K. Macrophage polarization: Different gene signatures in M1(LPS+) vs. classically and M2(LPS–) vs. alternatively activated macrophages. Front. Immunol., 2019, 10, 1084.
[http://dx.doi.org/10.3389/fimmu.2019.01084] [PMID: 31178859]

Yang, S.; Yuan, H.Q.; Hao, Y.M.; Ren, Z.; Qu, S.L.; Liu, L.S.; Wei, D.H.; Tang, Z.H.; Zhang, J.F.; Jiang, Z.S. Macrophage polarization in atherosclerosis. Clin. Chim. Acta, 2020, 501, 142-146.
[http://dx.doi.org/10.1016/j.cca.2019.10.034] [PMID: 31730809]

Gao, X.; Ge, J.; Li, W.; Zhou, W.; Xu, L. LncRNA KCNQ1OT1 ameliorates particle-induced osteolysis through inducing macrophage polarization by inhibiting miR-21a-5p. Biol. Chem., 2018, 399(4), 375-386.
[http://dx.doi.org/10.1515/hsz-2017-0215] [PMID: 29252185]

Cho, K.Y.; Miyoshi, H.; Kuroda, S.; Yasuda, H.; Kamiyama, K.; Nakagawara, J.; Takigami, M.; Kondo, T.; Atsumi, T. The phenotype of infiltrating macrophages influences arteriosclerotic plaque vulnerability in the carotid artery. J. Stroke Cerebrovasc. Dis., 2013, 22(7), 910-918.
[http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2012.11.020] [PMID: 23273713]

Ye, J.; Wang, C.; Wang, D.; Yuan, H. LncRBA GSA5, up-regulated by ox-LDL, aggravates inflammatory response and MMP expression in THP-1 macrophages by acting like a sponge for miR-221. Exp. Cell Res., 2018, 369(2), 348-355.
[http://dx.doi.org/10.1016/j.yexcr.2018.05.039] [PMID: 29859752]

Li, T.; Ding, L.; Wang, Y.; Yang, O.; Wang, S.; Kong, J. Genetic deficiency of Phactr1 promotes atherosclerosis development via facilitating M1 macrophage polarization and foam cell formation. Clin. Sci., 2020, 134(17), 2353-2368.
[http://dx.doi.org/10.1042/CS20191241] [PMID: 32857129]

Wang, L.; Zheng, Z.; Feng, X.; Zang, X.; Ding, W.; Wu, F.; Zhao, Q. circRNA/lncRNA-miRNA-mRNA network in oxidized, low-density, lipoprotein-induced foam cells. DNA Cell Biol., 2019, 38(12), 1499-1511.
[http://dx.doi.org/10.1089/dna.2019.4865] [PMID: 31804889]

Wang, X.; Bai, M. CircTM7SF3 contributes to oxidized low-density lipoprotein-induced apoptosis, inflammation and oxidative stress through targeting miR-206/ASPH axis in atherosclerosis cell model in vitro. BMC Cardiovasc. Disord., 2021, 21(1), 51.
[http://dx.doi.org/10.1186/s12872-020-01800-x] [PMID: 33526034]

Li, Y.; He, P.P.; Zhang, D.W.; Zheng, X.L.; Cayabyab, F.S.; Yin, W.D.; Tang, C.K. Lipoprotein lipase: From gene to atherosclerosis. Atherosclerosis, 2014, 237(2), 597-608.
[http://dx.doi.org/10.1016/j.atherosclerosis.2014.10.016] [PMID: 25463094]

Zhen, Z.; Ren, S.; Ji, H.; Ding, X.; Zou, P.; Lu, J. The lncRNA DAPK-IT1 regulates cholesterol metabolism and inflammatory response in macrophages and promotes atherogenesis. Biochem. Biophys. Res. Commun., 2019, 516(4), 1234-1241.
[http://dx.doi.org/10.1016/j.bbrc.2019.06.113] [PMID: 31300197]

Martinet, W.; Coornaert, I.; Puylaert, P.; De Meyer, G.R.Y. Macrophage death as a pharmacological target in atherosclerosis. Front. Pharmacol., 2019, 10, 306.
[http://dx.doi.org/10.3389/fphar.2019.00306] [PMID: 31019462]

Boada-Romero, E.; Martinez, J.; Heckmann, B.L.; Green, D.R. The clearance of dead cells by efferocytosis. Nat. Rev. Mol. Cell Biol., 2020, 21(7), 398-414.
[http://dx.doi.org/10.1038/s41580-020-0232-1] [PMID: 32251387]

Kourtzelis, I.; Hajishengallis, G.; Chavakis, T. Phagocytosis of apoptotic cells in resolution of inflammation. Front. Immunol., 2020, 11, 553.
[http://dx.doi.org/10.3389/fimmu.2020.00553] [PMID: 32296442]

Linton, M.F.; Babaev, V.R.; Huang, J.; Linton, E.F.; Tao, H.; Yancey, P.G. Macrophage apoptosis and efferocytosis in the pathogenesis of atherosclerosis. Circ. J., 2016, 80(11), 2259-2268.
[http://dx.doi.org/10.1253/circj.CJ-16-0924] [PMID: 27725526]

Mueller, P.A.; Kojima, Y.; Huynh, K.T.; Maldonado, R.A.; Ye, J.; Tavori, H.; Pamir, N.; Leeper, N.J.; Fazio, S. Macrophage LRP1 (low-density lipoprotein receptor-related protein 1) is required for the effect of CD47 blockade on efferocytosis and atherogenesis—brief report. Arterioscler. Thromb. Vasc. Biol., 2022, 42(1), e1-e9.
[http://dx.doi.org/10.1161/ATVBAHA.121.316854] [PMID: 34758632]

Ye, Z.; Yang, S.; Xia, Y.; Hu, R.; Chen, S.; Li, B.; Chen, S.; Luo, X.; Mao, L.; Li, Y.; Jin, H.; Qin, C.; Hu, B. LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 up-regulation. Cell Death Dis., 2019, 10(2), 138.
[http://dx.doi.org/10.1038/s41419-019-1409-4] [PMID: 30755588]

González-Navarro, H.; Abu Nabah, Y.N.; Vinué, Á.; Andrés-Manzano, M.J.; Collado, M.; Serrano, M.; Andrés, V. p19(ARF) deficiency reduces macrophage and vascular smooth muscle cell apoptosis and aggravates atherosclerosis. J. Am. Coll. Cardiol., 2010, 55(20), 2258-2268.
[http://dx.doi.org/10.1016/j.jacc.2010.01.026] [PMID: 20381282]

Yan, L.; Liu, Z.; Yin, H.; Guo, Z.; Luo, Q. Silencing of MEG3 inhibited ox‐LDL‐induced inflammation and apoptosis in macrophages via modulation of the MEG3/miR‐204/CDKN2A regulatory axis. Cell Biol. Int., 2019, 43(4), 409-420.
[http://dx.doi.org/10.1002/cbin.11105] [PMID: 30672051]

An, J.H.; Chen, Z.Y.; Ma, Q.L.; Wang, H.J.; Zhang, J.Q.; Shi, F.W. LncRNA SNHG16 promoted proliferation and inflammatory response of macrophages through miR-17-5p/NF-κB signaling pathway in patients with atherosclerosis. Eur Rev Med Pharmaco, 2019, 23(19), 8665-8677.
[PMID: 31646601]

Shi, Z.; Zheng, Z.; Lin, X.; Ma, H. Long noncoding RNA MALAT1 regulates the progression of atherosclerosis by miR-330-5p/NF-κB signal pathway. J. Cardiovasc. Pharmacol., 2021, 78(2), 235-246.
[http://dx.doi.org/10.1097/FJC.0000000000001061] [PMID: 34554676]

Liu, J.; Huang, G.Q.; Ke, Z.P. Silence of long intergenic noncoding RNA HOTAIR ameliorates oxidative stress and inflammation response in ox‐LDL‐treated human macrophages by up-regulating miR‐330‐5p. J. Cell. Physiol., 2019, 234(4), 5134-5142.
[http://dx.doi.org/10.1002/jcp.27317] [PMID: 30187491]

Jarosz, M.; Olbert, M.; Wyszogrodzka, G.; Młyniec, K.; Librowski, T. Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-κB signaling. Inflammopharmacology, 2017, 25(1), 11-24.
[http://dx.doi.org/10.1007/s10787-017-0309-4] [PMID: 28083748]

He, L.; Zhao, X.; He, L. LINC01140 alleviates the oxidized low-density lipoprotein-induced inflammatory response in macrophages via suppressing miR-23b. Inflammation, 2020, 43(1), 66-73.
[http://dx.doi.org/10.1007/s10753-019-01094-y] [PMID: 31748847]

He, Q.; Shao, D.; Hao, S.; Yuan, Y.; Liu, H.; Liu, F.; Mu, Q. CircSCAP aggravates oxidized low-density lipoprotein-induced macrophage injury by up-regulating PDE3B by miR-221-5p in atherosclerosis. J. Cardiovasc. Pharmacol., 2021, 78(5), e749-e760.
[http://dx.doi.org/10.1097/FJC.0000000000001118] [PMID: 34321402]

Wen, L.; Yang, Q.H.; Ma, X.L.; Li, T.; Xiao, S.; Sun, C.F. Inhibition of TNFAIP1 ameliorates the oxidative stress and inflammatory injury in myocardial ischemia/reperfusion injury through modulation of Akt/GSK-3β/Nrf2 pathway. Int. Immunopharmacol., 2021, 99, 107993.
[http://dx.doi.org/10.1016/j.intimp.2021.107993] [PMID: 34330059]

Xu, C.; Chen, L.; Wang, R.J.; Meng, J. LncRNA KCNQ1OT1 knockdown inhibits ox-LDL-induced inflammatory response and oxidative stress in THP-1 macrophages through the miR-137/TNFAIP1 axis. Cytokine, 2022, 155, 155912.
[http://dx.doi.org/10.1016/j.cyto.2022.155912] [PMID: 35598525]

Han, Y.; Ma, J.; Wang, J.; Wang, L. Silencing of H19 inhibits the adipogenesis and inflammation response in ox-LDL-treated Raw264.7 cells by up-regulating miR-130b. Mol. Immunol., 2018, 93, 107-114.
[http://dx.doi.org/10.1016/j.molimm.2017.11.017] [PMID: 29172088]

Liang, H.; Yang, K.; Xin, M.; Liu, X.; Zhao, L.; Liu, B.; Wang, J. MiR-130a protects against lipopolysaccharide-induced glomerular cell injury by up-regulation of Klotho. Pharmazie, 2017, 72(8), 468-474.
[PMID: 29441906]

Zhang, Y.; Lu, X.; Yang, M.; Shangguan, J.; Yin, Y. GAS5 knockdown suppresses inflammation and oxidative stress induced by oxidized low-density lipoprotein in macrophages by sponging miR-135a. Mol. Cell. Biochem., 2021, 476(2), 949-957.
[http://dx.doi.org/10.1007/s11010-020-03962-w] [PMID: 33128668]

Du, X.J.; Lu, J.M. MiR‐135a represses oxidative stress and vascular inflammatory events viatargeting toll‐like receptor 4 in atherogenesis. J. Cell. Biochem., 2018, 119(7), 6154-6161.
[http://dx.doi.org/10.1002/jcb.26819] [PMID: 29663503]

Huynh, D.T.N.; Heo, K.S. Role of mitochondrial dynamics and mitophagy of vascular smooth muscle cell proliferation and migration in progression of atherosclerosis. Arch. Pharm. Res., 2021, 44(12), 1051-1061.
[http://dx.doi.org/10.1007/s12272-021-01360-4] [PMID: 34743301]

Lee, H.S.; Yun, S.J.; Ha, J.M.; Jin, S.Y.; Ha, H.K.; Song, S.H.; Kim, C.D.; Bae, S.S. Prostaglandin D2 stimulates phenotypic changes in vascular smooth muscle cells. Exp. Mol. Med., 2019, 51(11), 1-10.
[http://dx.doi.org/10.1038/s12276-019-0330-3] [PMID: 31735914]

Bennett, M.R.; Sinha, S.; Owens, G.K. Vascular smooth muscle cells in atherosclerosis. Circ. Res., 2016, 118(4), 692-702.
[http://dx.doi.org/10.1161/CIRCRESAHA.115.306361] [PMID: 26892967]

Wang, Y.; Dubland, J.A.; Allahverdian, S.; Asonye, E.; Sahin, B.; Jaw, J.E.; Sin, D.D.; Seidman, M.A.; Leeper, N.J.; Francis, G.A. Smooth muscle cells contribute the majority of foam cells in ApoE (Apolipoprotein E)-deficient mouse atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2019, 39(5), 876-887.
[http://dx.doi.org/10.1161/ATVBAHA.119.312434] [PMID: 30786740]

Peng, N.; Liu, J.; Gao, D.; Lin, R.; Li, R. Angiotensin II-induced C-reactive protein generation: Inflammatory role of vascular smooth muscle cells in atherosclerosis. Atherosclerosis, 2007, 193(2), 292-298.
[http://dx.doi.org/10.1016/j.atherosclerosis.2006.09.007] [PMID: 17055513]

Allahverdian, S.; Chaabane, C.; Boukais, K.; Francis, G.A.; Bochaton-Piallat, M.L. Smooth muscle cell fate and plasticity in atherosclerosis. Cardiovasc. Res., 2018, 114(4), 540-550.
[http://dx.doi.org/10.1093/cvr/cvy022] [PMID: 29385543]

Qi, M.; Xin, S. FGF signaling contributes to atherosclerosis by enhancing the inflammatory response in vascular smooth muscle cells. Mol. Med. Rep., 2019, 20(1), 162-170.
[http://dx.doi.org/10.3892/mmr.2019.10249] [PMID: 31115530]

Ananyeva, N.M.; Tjurmin, A.V.; Berliner, J.A.; Chisolm, G.M.; Liau, G.; Winkles, J.A.; Haudenschild, C.C. Oxidized LDL mediates the release of fibroblast growth factor-1. Arterioscler. Thromb. Vasc. Biol., 1997, 17(3), 445-453.
[http://dx.doi.org/10.1161/01.ATV.17.3.445] [PMID: 9102162]

Zhang, L.; Cheng, H.; Yue, Y.; Li, S.; Zhang, D.; He, R. TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1. Cardiovasc. Pathol., 2018, 33, 6-15.
[http://dx.doi.org/10.1016/j.carpath.2017.11.004] [PMID: 29268138]

Abid, M.R.; Yano, K.; Guo, S.; Patel, V.I.; Shrikhande, G.; Spokes, K.C.; Ferran, C.; Aird, W.C. Forkhead transcription factors inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia. J. Biol. Chem., 2005, 280(33), 29864-29873.
[http://dx.doi.org/10.1074/jbc.M502149200] [PMID: 15961397]

Brown, J.; Wang, H.; Suttles, J.; Graves, D.T.; Martin, M. Mammalian target of rapamycin complex 2 (mTORC2) negatively regulates Toll-like receptor 4-mediated inflammatory response viaFoxO1. J. Biol. Chem., 2011, 286(52), 44295-44305.
[http://dx.doi.org/10.1074/jbc.M111.258053] [PMID: 22045807]

Li, X.; Li, L.; Dong, X.; Ding, J.; Ma, H.; Han, W. Circ_GRN promotes the proliferation, migration, and inflammation of vascular smooth muscle cells in atherosclerosis through miR-214-3p/FOXO1 axis. J. Cardiovasc. Pharmacol., 2021, 77(4), 470-479.
[http://dx.doi.org/10.1097/FJC.0000000000000982] [PMID: 33818550]

Urrego, D.; Tomczak, A.P.; Zahed, F.; Stühmer, W.; Pardo, L.A. Potassium channels in cell cycle and cell proliferation. Philos. Trans. R. Soc. Lond. B Biol. Sci., 2014, 369(1638), 20130094.
[http://dx.doi.org/10.1098/rstb.2013.0094] [PMID: 24493742]

Lao, K.H.; Zeng, L.; Xu, Q. Endothelial and smooth muscle cell transformation in atherosclerosis. Curr. Opin. Lipidol., 2015, 26(5), 449-456.
[http://dx.doi.org/10.1097/MOL.0000000000000219] [PMID: 26218417]

Zhang, P.; Wang, W.; Li, M. Circ_0010283/miR-377-3p/Cyclin D1 axis is associated with proliferation, apoptosis, migration, and inflammation of oxidized low-density lipoprotein-stimulated vascular smooth muscle cells. J. Cardiovasc. Pharmacol., 2021, 78(3), 437-447.
[http://dx.doi.org/10.1097/FJC.0000000000001076] [PMID: 34516453]

Luftman, K.; Hasan, N.; Day, P.; Hardee, D.; Hu, C. Silencing of VAMP3 inhibits cell migration and integrin-mediated adhesion. Biochem. Biophys. Res. Commun., 2009, 380(1), 65-70.
[http://dx.doi.org/10.1016/j.bbrc.2009.01.036] [PMID: 19159614]

Zhu, J.J.; Liu, Y.F.; Zhang, Y.P.; Zhao, C.R.; Yao, W.J.; Li, Y.S.; Wang, K.C.; Huang, T.S.; Pang, W.; Wang, X.F.; Wang, X.; Chien, S.; Zhou, J. VAMP3 and SNAP23 mediate the disturbed flow-induced endothelial microRNA secretion and smooth muscle hyperplasia. Proc. Natl. Acad. Sci., 2017, 114(31), 8271-8276.
[http://dx.doi.org/10.1073/pnas.1700561114] [PMID: 28716920]

Li, R.; Jiang, Q.; Zheng, Y. Circ_0002984 induces proliferation, migration and inflammation response of VSMCs induced by ox‐LDL through miR 326‐3p/VAMP3 axis in atherosclerosis. J. Cell. Mol. Med., 2021, 25(16), 8028-8038.
[http://dx.doi.org/10.1111/jcmm.16734] [PMID: 34169652]

Burger, F.; Baptista, D.; Roth, A.; da Silva, R.F.; Montecucco, F.; Mach, F.; Brandt, K.J.; Miteva, K. NLRP3 inflammasome activation controls vascular smooth muscle cells phenotypic switch in atherosclerosis. Int. J. Mol. Sci., 2021, 23(1), 340.
[http://dx.doi.org/10.3390/ijms23010340] [PMID: 35008765]

Chhibber-Goel, J.; Singhal, V.; Bhowmik, D.; Vivek, R.; Parakh, N.; Bhargava, B.; Sharma, A. Linkages between oral commensal bacteria and atherosclerotic plaques in coronary artery disease patients. NPJ Biofilms Microbiomes, 2016, 2(1), 7.
[http://dx.doi.org/10.1038/s41522-016-0009-7] [PMID: 28649401]

Suh, J.S.; Kim, S.; Boström, K.I.; Wang, C.Y.; Kim, R.H.; Park, N.H. Periodontitis-induced systemic inflammation exacerbates atherosclerosis partly via endothelial–mesenchymal transition in mice. Int. J. Oral Sci., 2019, 11(3), 21.
[http://dx.doi.org/10.1038/s41368-019-0054-1] [PMID: 31257363]

Liu, J.; Wang, Y.; Liao, Y.; Zhou, Y.; Zhu, J. Circular RNA PPP1CC promotes Porphyromonas gingivalis -lipopolysaccharide-induced pyroptosis of vascular smooth muscle cells by activating the HMGB1/TLR9/AIM2 pathway. J. Int. Med. Res., 2021, 49(3)
[http://dx.doi.org/10.1177/0300060521996564] [PMID: 33769113]

Lin, Y.; Huang, H.; Yu, Y.; Zhu, F.; Xiao, W.; Yang, Z.; Shao, L.; Shen, Z. Long non-coding RNA RP11-465L10.10 promotes vascular smooth muscle cells phenotype switching and MMP9 expression viathe NF-κB pathway. Ann. Transl. Med., 2021, 9(24), 1776.
[http://dx.doi.org/10.21037/atm-21-6402] [PMID: 35071470]

Ye, B.; Wu, Z.; Tsui, T.Y.; Zhang, B.; Su, X.; Qiu, Y.; Zheng, X. lncRNA KCNQ1OT1 suppresses the inflammation and proliferation of vascular smooth muscle cells through iκba in intimal hyperplasia. Mol. Ther. Nucleic Acids, 2020, 20, 62-72.
[http://dx.doi.org/10.1016/j.omtn.2020.01.032] [PMID: 32146419]

Kong, P.; Yu, Y.; Wang, L.; Dou, Y.Q.; Zhang, X.H.; Cui, Y.; Wang, H.Y.; Yong, Y.T.; Liu, Y.B.; Hu, H.J.; Cui, W.; Sun, S.G.; Li, B.H.; Zhang, F.; Han, M. circ-Sirt1 controls NF-κB activation via sequence-specific interaction and enhancement of SIRT1 expression by binding to miR-132/212 in vascular smooth muscle cells. Nucleic Acids Res., 2019, 47(7), 3580-3593.
[http://dx.doi.org/10.1093/nar/gkz141] [PMID: 30820544]

Wang, F.; Liu, Z.; Park, S.H.; Gwag, T.; Lu, W.; Ma, M.; Sui, Y.; Zhou, C. Myeloid β-catenin deficiency exacerbates atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol., 2018, 38(7), 1468-1478.
[http://dx.doi.org/10.1161/ATVBAHA.118.311059] [PMID: 29724817]

Marchand, A.; Atassi, F.; Gaaya, A.; Leprince, P.; Le Feuvre, C.; Soubrier, F.; Lompré, A.M.; Nadaud, S. The Wnt/beta-catenin pathway is activated during advanced arterial aging in humans. Aging Cell, 2011, 10(2), 220-232.
[http://dx.doi.org/10.1111/j.1474-9726.2010.00661.x] [PMID: 21108734]

Sun, H.; Feng, J.; Ma, Y.; Cai, D.; Luo, Y.; Wang, Q.; Li, F.; Zhang, M.; Hu, Q. RETRACTED ARTICLE: Down-regulation of microRNA-342-5p or Up-regulation of Wnt3a Inhibits Angiogenesis and Maintains Atherosclerotic Plaque Stability in Atherosclerosis Mice. Nanoscale Res. Lett., 2021, 16(1), 165.
[http://dx.doi.org/10.1186/s11671-021-03608-w] [PMID: 34807315]

Zhuang, J.B.; Li, T.; Hu, X.M.; Ning, M.; Gao, W.Q.; Lang, Y.H.; Zheng, W.F.; Wei, J. Circ_CHFR expedites cell growth, migration and inflammation in ox-LDL-treated human vascular smooth muscle cells via the miR-214-3p/Wnt3/β-catenin pathway. Eur Rev Med Pharmaco, 2020, 24(6), 3282-3292.
[PMID: 32271446]

Zhao, Y.; Zhang, J.; Zhang, W.; Xu, Y. A myriad of roles of dendritic cells in atherosclerosis. Clin. Exp. Immunol., 2021, 206(1), 12-27.
[http://dx.doi.org/10.1111/cei.13634] [PMID: 34109619]

Gil-Pulido, J.; Zernecke, A. Antigen-presenting dendritic cells in atherosclerosis. Eur. J. Pharmacol., 2017, 816, 25-31.
[http://dx.doi.org/10.1016/j.ejphar.2017.08.016] [PMID: 28822856]

Chen, L.; Hu, L.; Zhu, X.; Wang, Y.; Li, Q.; Ma, J.; Li, H. MALAT1 overexpression attenuates AS by inhibiting ox-LDL-stimulated dendritic cell maturation via miR-155-5p/NFIA axis. Cell Cycle, 2020, 19(19), 2472-2485.
[http://dx.doi.org/10.1080/15384101.2020.1807094] [PMID: 32840181]

Zhu, J.; Chen, Z.; Peng, X.; Zheng, Z.; Le, A.; Guo, J.; Ma, L.; Shi, H.; Yao, K.; Zhang, S.; Ge, J.; Zheng, Z.; Wang, Q. Extracellular vesicle-derived circitgb1 regulates dendritic cell maturation and cardiac inflammation via miR-342-3p/NFAM1. Oxid. Med. Cell. Longev., 2022, 2022, 1-23.
[http://dx.doi.org/10.1155/2022/8392313] [PMID: 35615580]

Poller, W.; Dimmeler, S.; Heymans, S.; Zeller, T.; Haas, J.; Karakas, M.; Leistner, D.M.; Jakob, P.; Nakagawa, S.; Blankenberg, S.; Engelhardt, S.; Thum, T.; Weber, C.; Meder, B.; Hajjar, R.; Landmesser, U. Non-coding RNAs in cardiovascular diseases: Diagnostic and therapeutic perspectives. Eur. Heart J., 2018, 39(29), 2704-2716.
[http://dx.doi.org/10.1093/eurheartj/ehx165] [PMID: 28430919]

Li, L.; Wang, L.; Li, H.; Han, X.; Chen, S.; Yang, B.; Hu, Z.; Zhu, H.; Cai, C.; Chen, J.; Li, X.; Huang, J.; Gu, D. Characterization of LncRNA expression profile and identification of novel LncRNA biomarkers to diagnose coronary artery disease. Atherosclerosis, 2018, 275, 359-367.
[http://dx.doi.org/10.1016/j.atherosclerosis.2018.06.866] [PMID: 30015300]

Chen, L.; Qu, H.; Guo, M.; Zhang, Y.; Cui, Y.; Yang, Q.; Bai, R.; Shi, D. ANRIL and atherosclerosis. J. Clin. Pharm. Ther., 2020, 45(2), 240-248.
[http://dx.doi.org/10.1111/jcpt.13060] [PMID: 31703157]

Zhang, Z.; Gao, W.; Long, Q.Q.; Zhang, J.; Li, Y.F. liu, D.C.; Yan, J.J.; Yang, Z.J.; Wang, L.S. Increased plasma levels of lncRNA H19 and LIPCAR are associated with increased risk of coronary artery disease in a Chinese population. Sci. Rep., 2017, 7(1), 7491.
[http://dx.doi.org/10.1038/s41598-017-07611-z] [PMID: 28790415]

Altesha, M.A.; Ni, T.; Khan, A.; Liu, K.; Zheng, X. Circular RNA in cardiovascular disease. J. Cell. Physiol., 2019, 234(5), 5588-5600.
[http://dx.doi.org/10.1002/jcp.27384] [PMID: 30341894]

Liang, B.; Li, M.; Deng, Q.; Wang, C.; Rong, J.; He, S.; Xiang, Y.; Zheng, F. CircRNA ZNF609 in peripheral blood leukocytes acts as a protective factor and a potential biomarker for coronary artery disease. Ann. Transl. Med., 2020, 8(12), 741.
[http://dx.doi.org/10.21037/atm-19-4728] [PMID: 32647666]

Jiang, Y.; Du, T. Relation of circulating lncRNA GAS5 and miR‐21 with biochemical indexes, stenosis severity, and inflammatory cytokines in coronary heart disease patients. J. Clin. Lab. Anal., 2022, 36(2), e24202.
[http://dx.doi.org/10.1002/jcla.24202] [PMID: 34997773]

Ayada, K.; Yokota, K.; Kobayashi, K.; Shoenfeld, Y.; Matsuura, E.; Oguma, K. Chronic infections and atherosclerosis. Ann. N. Y. Acad. Sci., 2007, 1108(1), 594-602.
[http://dx.doi.org/10.1196/annals.1422.062] [PMID: 17894024]

Teng, L.; Meng, R. Long non-coding RNA MALAT1 promotes acute cerebral infarction through miRNAs-Mediated hs-CRP regulation. J. Mol. Neurosci., 2019, 69(3), 494-504.
[http://dx.doi.org/10.1007/s12031-019-01384-y] [PMID: 31342266]

van Leuven, S.I.; Kastelein, J.J.P. Atorvastatin. Expert Opin. Pharmacother., 2005, 6(7), 1191-1203.
[http://dx.doi.org/10.1517/14656566.6.7.1191] [PMID: 15957972]

Björnsson, E.S. Hepatotoxicity of statins and other lipid-lowering agents. Liver Int., 2017, 37(2), 173-178.
[http://dx.doi.org/10.1111/liv.13308] [PMID: 27860156]

Ye, Y.; Zhao, X.; Lu, Y.; Long, B.; Zhang, S. Varinostat alters gene expression profiles in aortic tissues from ApoE −/– Mice. Hum. Gene Ther. Clin. Dev., 2018, 29(4), 214-225.
[http://dx.doi.org/10.1089/humc.2018.141] [PMID: 30284929]

Petrucci, G.; Rizzi, A.; Hatem, D.; Tosti, G.; Rocca, B.; Pitocco, D. Role of oxidative stress in the pathogenesis of atherothrombotic diseases. Antioxidants, 2022, 11(7), 1408.
[http://dx.doi.org/10.3390/antiox11071408] [PMID: 35883899]

Liu, Z.; Gan, L.; Xu, Y.; Luo, D.; Ren, Q.; Wu, S.; Sun, C. Melatonin alleviates inflammasome-induced pyroptosis through inhibiting NF-κB/GSDMD signal in mice adipose tissue. J. Pineal Res., 2017, 63(1), e12414.
[http://dx.doi.org/10.1111/jpi.12414] [PMID: 28398673]

Song, X.; Tan, L.; Wang, M.; Ren, C.; Guo, C.; Yang, B.; Ren, Y.; Cao, Z.; Li, Y.; Pei, J. Myricetin: A review of the most recent research. Biomed. Pharmacother., 2021, 134, 111017.
[http://dx.doi.org/10.1016/j.biopha.2020.111017] [PMID: 33338751]

Yang, L.J.; Jeng, C.J.; Kung, H.N.; Chang, C.C.; Wang, A.G.; Chau, G.Y.; Don, M.J.; Chau, Y.P. Tanshinone IIA isolated from Salvia miltiorrhiza elicits the cell death of human endothelial cells. J. Biomed. Sci., 2005, 12(2), 347-361.
[http://dx.doi.org/10.1007/s11373-005-0973-z] [PMID: 15917998]

Zhu, J.; Xu, Y.; Ren, G.; Hu, X.; Wang, C.; Yang, Z.; Li, Z.; Mao, W.; Lu, D.; Tanshinone, I.I.A.; Tanshinone, IIA. Sodium sulfonate regulates antioxidant system, inflammation, and endothelial dysfunction in atherosclerosis by downregulation of CLIC1. Eur. J. Pharmacol., 2017, 815, 427-436.
[http://dx.doi.org/10.1016/j.ejphar.2017.09.047] [PMID: 28970012]

Chen, W.; Guo, S.; Li, X.; Song, N.; Wang, D.; Yu, R. The regulated profile of noncoding RNAs associated with inflammation by tanshinone IIA on atherosclerosis. J. Leukoc. Biol., 2020, 108(1), 243-252.
[http://dx.doi.org/10.1002/JLB.3MA0320-327RRR] [PMID: 32337768]

Kong, X.L.; Lyu, Q.; Zhang, Y.Q.; Kang, D.F.; Li, C.; Zhang, L.; Gao, Z.C.; Liu, X.X.; Wu, J.B.; Li, Y.L. Effect of astragaloside IV and salvianolic acid B on antioxidant stress and vascular endothelial protection in the treatment of atherosclerosis based on metabonomics. Chin. J. Nat. Med., 2022, 20(8), 601-613.
[http://dx.doi.org/10.1016/S1875-5364(22)60186-9] [PMID: 36031232]

Fan, S.; Hu, Y.; You, Y.; Xue, W.; Chai, R.; Zhang, X.; Shou, X.; Shi, J. Role of resveratrol in inhibiting pathological cardiac remodeling. Front. Pharmacol., 2022, 13, 924473.
[http://dx.doi.org/10.3389/fphar.2022.924473] [PMID: 36120366]

Chen, J.; Liu, Y.; Liu, Y.; Peng, J. Resveratrol protects against ox-LDL-induced endothelial dysfunction in atherosclerosis via depending on circ_0091822/miR-106b-5p-mediated up-regulation of TLR4. Immunopharmacol. Immunotoxicol., 2022, 44(6), 915-924.
[http://dx.doi.org/10.1080/08923973.2022.2093740] [PMID: 35736860]

Wu, Y.; Zhang, F.; Li, X.; Hou, W.; Zhang, S.; Feng, Y.; Lu, R.; Ding, Y.; Sun, L. Systematic analysis of lncRNA expression profiles and atherosclerosis-associated lncRNA-mRNA network revealing functional lncRNAs in carotid atherosclerotic rabbit models. Funct. Integr. Genomics, 2020, 20(1), 103-115.
[http://dx.doi.org/10.1007/s10142-019-00705-z] [PMID: 31392586]

Wang, X. A PCR-based platform for microRNA expression profiling studies. RNA, 2009, 15(4), 716-723.
[http://dx.doi.org/10.1261/rna.1460509] [PMID: 19218553]

Hung, J.H.; Weng, Z. Analysis of microarray and RNA-seq expression profiling data. Cold Spring Harb. Protoc., 2017, 2017(3) pdb.top093104.
[http://dx.doi.org/10.1101/pdb.top093104] [PMID: 27574194]

Wang, L.; Long, H.; Zheng, Q.; Bo, X.; Xiao, X.; Li, B. Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression. Mol. Cancer, 2019, 18(1), 119.
[http://dx.doi.org/10.1186/s12943-019-1046-7] [PMID: 31324186]

Chen, J.; Huang, X.; Wang, W.; Xie, H.; Li, J.; Hu, Z.; Zheng, Z.; Li, H.; Teng, L. LncRNA CDKN2BAS predicts poor prognosis in patients with hepatocellular carcinoma and promotes metastasis via the miR-153-5p/ARHGAP18 signaling axis. Aging., 2018, 10(11), 3371-3381.
[http://dx.doi.org/10.18632/aging.101645] [PMID: 30510148]